Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 1998

View Archived Issues

IL-15 potentiates antitumor activity of 5-FU/leucovorin in colorectal cancer

Neuroprotective effects of YM-39558, a potential treatment for stroke

Sabcomeline treatment results in cognitive enhancement in nonhuman primates

Prevention of diabetes with nicotinamide -- the DENIS multicenter study

Idoxifene: another SERM with clinical potential in postmenopausal disorders

Interneuron initiates phase III CerAxon study and licenses citicoline patent rights to Ferrer

New evidence supports the efficacy of PKC inhibition in diabetic neuropathy

Vitamin D analogue EB-1089 acts via effects on IGF-I

EM-800, a more potent antiestrogen than raloxifene in preclinical studies

Alexion initiates C5 inhibitor phase I/II clinical trial for rheumatoid arthritis

Anergen initiates clinical trials with AnergiX

Vivus seeks partner to promote Muse in the U.S.

Preclinical overview of nepicastat cardiovascular effects

NPY Y1 receptor agonists from Ortho with anxiolytic activity

Hydroxamic acid-based MMP inhibitors described by P&U

Vertex describes new protease inhibitors as therapeutics for HCV

Merck & Co.'s new tachykinin antagonists

SS Pharm. presents novel ACAT inhibitors for arteriosclerosis

Advisory committee recommends approval of Pletal

Zyrtec registered in Japan, launch scheduled for September

Phase III trial of new foam formulation of clobetasol initiated

Spotlight on estrone sulfatase inhibitors for treatment of breast cancer

Potent, broad-spectrum antitumor arylsulfonylimidazolidinone selected by Dong Wha

Sanwa Kagaku selects optically active candidate gastric prokinetic agent

Panels report guidelines for HIV and CMV therapy